Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisella Vischini

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Clinical Kidney Journal|January 29, 2026
Low protein diet with personalized support in advanced chronic kidney disease: association with disease progression, dialysis delay and mortalityGisella Vischini, Sara Caissutti, Daniele Vetrano, et al.
The American Journal of Case Reports|February 23, 2022
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case ReportGabriele Donati, Chiara Abenavoli, Gisella Vischini, et al.
Expert Review of Anticancer Therapy|March 11, 2010
Pain management in multiple myelomaPasquale Niscola, Laura Scaramucci, Claudio Romani, et al.
Orphanet Journal of Rare Diseases|September 2, 2025
Functional and histopathologic correlation in the fabry nephropathy with N215S genotypeRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
Plos One|July 29, 2016
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) InjuryValentina Masola, Gianluigi Zaza, Giovanni Gambaro, et al.
The Lancet. Infectious Diseases|March 13, 2025
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literatureGian Marco Berti, Elisabetta Manaresi, Gisella Vischini, et al.
Frontiers in Medicine|November 16, 2020
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination TherapiesLuca Petricca, Maria Rita Gigante, Annamaria Paglionico, et al.
European Journal of Human Genetics : EJHG|March 19, 2015
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathyAnnamaria Milillo, Francesca La Carpia, Stefano Costanzi, et al.
Proteomics. Clinical Applications|October 26, 2018
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor as a Possible Indicator of Response to Therapy in Membranous NephropathyVincenzo L'Imperio, Andrew Smith, Elena Ajello, et al.
Biomedicines|April 29, 2025
The Role of Kidney Biopsy in Fabry DiseaseIrene Capelli, Laura Martano, Gian Marco Berti, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Clinical Kidney Journal|January 29, 2026
Low protein diet with personalized support in advanced chronic kidney disease: association with disease progression, dialysis delay and mortalityGisella Vischini, Sara Caissutti, Daniele Vetrano, et al.
The American Journal of Case Reports|February 23, 2022
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case ReportGabriele Donati, Chiara Abenavoli, Gisella Vischini, et al.
Expert Review of Anticancer Therapy|March 11, 2010
Pain management in multiple myelomaPasquale Niscola, Laura Scaramucci, Claudio Romani, et al.
Orphanet Journal of Rare Diseases|September 2, 2025
Functional and histopathologic correlation in the fabry nephropathy with N215S genotypeRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
Plos One|July 29, 2016
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) InjuryValentina Masola, Gianluigi Zaza, Giovanni Gambaro, et al.
The Lancet. Infectious Diseases|March 13, 2025
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literatureGian Marco Berti, Elisabetta Manaresi, Gisella Vischini, et al.
Frontiers in Medicine|November 16, 2020
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination TherapiesLuca Petricca, Maria Rita Gigante, Annamaria Paglionico, et al.
European Journal of Human Genetics : EJHG|March 19, 2015
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathyAnnamaria Milillo, Francesca La Carpia, Stefano Costanzi, et al.
Proteomics. Clinical Applications|October 26, 2018
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor as a Possible Indicator of Response to Therapy in Membranous NephropathyVincenzo L'Imperio, Andrew Smith, Elena Ajello, et al.
Biomedicines|April 29, 2025
The Role of Kidney Biopsy in Fabry DiseaseIrene Capelli, Laura Martano, Gian Marco Berti, et al.
Pageof 5